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Without question, this is the most comprehensive, almost
encyclopaedic textbook on leukaemias, myeloproliferative
and myelodysplastic syndromes and lymphomas presently
available. Written by a large number of authorities in differ-
ent fields, the book is divided into five sections (chronic leu-
kaemias and related disorders; acute leukaemias; myeloma
and related disorders; lymphomas; supportive care). Each
section begins with a chapter on historical perspectives that
is fascinating to read and at the same time useful because it
leads the reader to realise the enormous progress that has
been achieved during the last century and particularly during
the last 40 years. Epidemiology, pathology and morphology,
molecular biology, immunobiology, genetics, classification,
staging and treatment of various disease entities follow, and
each chapter ends with an unbeatable collection of hundreds
of references. Probably unavoidable are repetitions in a num-
ber of chapters, and the question arises whether the authors
of the various chapters always knew about the content of the
preceding and following ones. Considerable efforts have
been undertaken to present up to date knowledge, success-
fully so in the majority of chapters. The chapter on cyto-
chemical and morphological classification of acute
leukaemias, however, is outdated: immunophenotyping of
acute lymphoblastic leukaemia (ALL) is not only ‘useful’
but mandatory, and the FAB classification of ALL has
become irrelevant. The authors should have concentrated on
the WHO classification rather than presenting a confusing
hybrid of FAB and WHO for acute leukaemias and myelo-
dysplastic syndromes. For the lymphomas, the WHO classifi-
cation has been used consequently. Particularly valuable is
the section on supportive care, which covers prevention,
diagnosis and treatment of bacterial, fungal and viral infec-
tions, transfusion medicine including haematopoietic stem
cell support, various aspects of allotransplantation, growth
factor support and psychological aspects of patients with
haematological neoplasias.
As stated in the preface, it was the editors’ aim to design an
encyclopaedic resource for established haematologists and
medical oncologists taking care of adults and children. The
reviewer believes that this aim has been achieved magnifi-
cently. This is a carefully edited, very good book, and nothing
comparable is on the market.
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No fewer than three prominent professors have been recruited
to write forewords to this revised edition of a rather successful
book on ‘molecular oncology’, a field very much in the lime-
light these days. Its content is described in the editorials as a
‘bold look at the evolution of our knowledge of cancer’, as a
‘lucid . . . account of . . . one of the genuine success stories of
molecular medicine’, and as ‘providing valuable information
for the continuing education of all oncologists.’ A quick
browse through its pages, and much more so some concen-
trated reading of excerpts from its columns will prove, that
the editorialists do not exaggerate. There is indeed much valu-
able information in each of the chapters, the references are
extensive (typically several 100 per section) and updated to
the year 2003. I particularly liked chapter 9 on ‘Growth factor
signalling pathways in cancer’, where entire molecular path-
ways are described rather than redundant lists of single cancer
genes. The essay on oestrogen action and breast cancer (sec-
tion 10) is to my mind particularly authoritative and concise,
just as much as chapter 6 on ‘Molecular diagnostics of can-
cer’, which provides a neat overview of tumour clonality ana-
lyses, molecular cytogenetics and expression profiling. All is
well then, and nothing to criticise? Not quite, I am afraid,
since I do need to bring up a number of quibbles. They do not
really mar the overall appeal of this book, but some points
could have been improved, and must be taken care of in future
editions. I fail to see why ‘traditional’ circulating serum
tumour markers such as AFP or CEA find a place in this
book, and there are far better overviews on these routine mar-
kers available in the literature and in many textbooks of
oncology. The chapter on the ‘Clinical importance of prognos-
tic factors’ is certainly well written, but it does not focus on
molecular oncology, nor are its data derived to any great
extent from molecular studies. Why discuss BCL-1 and BCL-
2 twice in separate sections of the same chapter on ‘Genetic
markers in sporadic tumours’? The opening article on
Annals of Oncology 16: 175–176, 2005
q 2005 European Society for Medical Oncology
‘The right targets for cancer therapy’ turns out to be a very
broad survey of topics such as diets in cancer, molecular
oncology (as you would expect), tumour clonality issues,
trends in mortality due to cancer, hereditary predisposition to
cancer, and others. Whilst I do not deny that these various
issues, heterogeneous as they are, are well discussed, I some-
what miss a clear focus of this chapter. Finally, the graphic
presentation of the book is less than ideal, with too few tables,
and too few explanatory figures or graphs. It has been said
that a picture is worth a thousand words or so. Perhaps this
advice might also be considered for oncology textbooks such
as this one. On a positive vein, the various chapters are written
in an authoritative style and in a timely fashion. For clinical
oncologists without a specific interest in the molecular biology
of cancer, and for medical students, the book is perhaps too
detailed and too basic. However, anyone working on cancer
problems in an academic setting will be able to pull out much
valuable information from this work’s columns.
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